Neisseria meningitidis serogroup W-135 carriage among US travelers to the 2001 Hajj

Journal of Infectious Diseases

Volumn 191, Issue 1, 2005, Pages 33-39

  Dull, Peter M ^a,b   Abdelwahab, Jalaa' ^d   Sacchi, Claudio T ^b   Backer, Margaret ^c   Noble, Corie A ^b   Barnett, Gwen A ^b   Kaiser, Robyn M ^b   Mayer, Leonard W ^b   Whitney, Anne M ^b   Schmink, Susanna ^b   Ajello, Gloria W ^b   Dolan Livengood, Jennifer ^e   Stephens, David S ^b,e   Cetron, Marry S ^c   Popovic, Tanja ^b   Rosenstein, Nancy E ^b  

^a Epidemiology and Analysis Program Office   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIUM CARRIER; BACTERIUM ISOLATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRAVEL; UNITED STATES; VACCINATION;

EID: 19944405752     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/425927     Document Type: Article

References (25)

1. Edwards MS, Baker CJ. Complications and sequelae of meningococcal infections in children. J Pediatr 1981; 99:540-5.
2. Cartwright KA, Stuart JM, Jones DM, Noah ND. The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect 1987; 99:591-601.
3. Broome CV. The carrier state: Neisseria meningitidis. J Antimicrob Chemother 1986; 18(Suppl A):25-34.
4. Novelli VM, Lewis RG, Dawood ST. Epidemic group A meningococcal disease in Haj pilgrims [letter]. Lancet 1987; 2:863.
5. Moore PS, Harrison LH, Telzak EE, Ajello GW, Broome CV. Group A meningococcal carriage in travelers returning from Saudi Arabia. JAMA 1988; 260:2686-9.
6. Advisory Committee on Immunization Practices. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2000; 49(RR-7):1-10.
7. Mayer LW, Reeves MW, Al-Hamdan N, et al. Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electrophoretic type-37 complex. J Infect Dis 2002; 185:1596-605.
8. Rosenstein NE, Perkins BA, Stephens DS, et al. The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis 1999; 180:1894-901.
9. Popovic T, Ajello G, Facklam R. Manual for the laboratory diagnosis of meningitis caused by Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae. Geneva: World Health Organization, 1999.
10. Frosch M, Weisgerber C, Meyer TF. Molecular characterization and expression in Escherichia coli of the gene complex encoding the polysaccharide capsule of Neisseria meningitidis group B. Proc Natl Acac Sci USA 1989; 86:1669-73.
11. Mothershed EA, Sacchi CT, Whitney AM, et al. Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis. J Clin Microbiol 2004; 42:320-8.
12. Popovic T, Schmink S, Rosenstein NA, et al. Evaluation of pulsed-field gel electrophoresis in epidemiological investigations of meningococcal disease outbreaks caused by Neisseria meningitidis serogroup C. J Clin Microbiol 2001; 39:75-85.
13. Sacchi CT, Whitney AM, Reeves MW, Mayer LW, Popovic T. Sequence diversity of Neisseria meningitidis 16S rRNA genes and use of 16S rRNA gene sequencing as a molecular subtyping tool. J Clin Microbiol 2002; 40:4520-7.
14. Sacchi CT, Whitney AM, Popovic T, et al. Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998. J Infect Dis 2000; 182:1169-76.
15. Dolan-Livengood JM, Miller YK, Martin LE, Urwin R, Stephens DS. Genetic basis for nongroupable Neisseria meningitidis. J Infect Dis 2003; 187:1616-28.
16. Kahler CM, Martin LE, Shih GC, Rahman MM, Carlson RW, Stephens DS. The (α2→8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum. Infect Immun 1998; 66:5939-47.
17. WHO. Meningococcal disease, serogroup W135 (update). Wkly Epidemiol Rec 2001; 76:213-6.
18. Henserson S, Handford S, Ramsay M. Neisseria meningitidis W135: 2a: P1.2,5 arising from successive pilgrimages to Mecca. Eurosurveillance Weekly 2001; 5. Available at: http://www.eurosurveillance.org/ew/2001/010419.sp. Accessed 8 November 2004.
19. Issack MI, Ragavoodoo C. Hajj-related Neisseria meningitidis serogroup w135 in Mauritius. Emerg Infect Dis 2002; 8:332-4.
20. Wilder-Smith A, Barkham TM, Earnest A, Paton NI. Acquisition of W135 meningococcal carriage in Hajj pilgrims and transmission to household contacts: prospective study. BMJ 2002; 325:365-6.
21. Balkhy HH, Memish ZA, Osoba AO. Meningococcal carriage among local inhabitants during the pilgrimage 2000-2001. Int J Antimicrob Agents 2003; 21:107-11.
22. Centers for Disease Control and Prevention (CDC). Active bacterial core surveillance reports, emerging infections program network, Neisseria meningitidis. Available at: http://www.cdc.gov.ncidod/dbmd/abcs/survreports.htm. Accessed 8 November 2004.
23. Hammerschmidt S, Hilse R, van Putten JP, Gerardy-Schahn R, Unkmeir A, Frosch M. Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element. EMBO J 1996; 15:192-8.
24. Tsang RS, Law D, Squires SG. Two serologically non-groupable Neisseria meningitidis strains from clinical specimens identified by molecular method as serogroup B meningococci. Can Commun Dis Rep 2001; 27:9-12.
25. Vogel U, Morelli G, Zurth K, et al. Necessity of molecular techniques to distinguish between Neisseria meningitidis strains isolated from patients with meningococcal disease and from their healthy contacts. I Clin Microbiol 1998; 36:2465-70.